CUSIP 30233G209COM NEWEYPTQ4 2025
42 filings · latest Feb 24, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 8.27M | $151.00M |
| 2 | Suvretta Capital Management, LLC | 7.83M | $143.01M |
| 3 | Blackrock, Inc. | 6.79M | $124.01M |
| 4 | Federated Hermes, Inc. | 6.02M | $109.94M |
| 5 | Franklin Resources Inc | 4.98M | $90.93M |
| 6 | Vanguard Group Inc | 4.82M | $88.10M |
| 7 | Adage Capital Partners Gp, L.L.C. | 4.70M | $85.87M |
| 8 | Paradigm Biocapital Advisors LP | 3.69M | $67.44M |
| 9 |
| 4 | Dec 8, 2025 | Cormorant Asset Management, LP | 13G/A | 10.0% | 8.27M | SEC |
| 5 | Nov 13, 2025 | Adage Capital Management, L.P. | 13G/A | 8.1% | 5.56M | SEC |
| 6 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 6.5% | 4.49M | SEC |
| 7 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 9.9% | 6.80M | SEC |
| 8 | Jul 8, 2025 | Federated Hermes, Inc. | 13G/A | 6.7% | 4.60M | SEC |
| 9 | Feb 14, 2025 | Ra Capital Management, L.P. | 13G/A | 4.7% | 3.18M | SEC |
| 10 | Feb 12, 2025 | Adage Capital Management, L.P. | 13G/A | 8.4% | 5.75M | SEC |
See the full Schedule 13D/13G history for Eyepoint Pharmaceuticals Inc.
Unlock full history| Tcg Crossover Management, LLC |
| 3.57M |
| $65.27M |
| 10 | Janus Henderson Group PLC | 2.94M | $53.66M |